-- Shire declines to comment on any specifics of 'M&A frenzy'
-- 
-- Thu May 01, 2014 08:02AM EDT
-- None



LONDON, May 1 (Reuters) - The chief executive of pharmaceutical company Shire <SHP.L> declined to comment on Thursday on any takeover interest the company may have received, saying he could not talk about the specifics of the "M&A frenzy" gripping the sector.

Allergan Inc <AGN.N>, the botox maker, is preparing a takeover approach for Dublin-based Shire, Reuters reported on Tuesday. [ID:nL6N0NL25Z]